Stay updated on Pimavanserin Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, appears in the Record History, replacing the previous v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T02:09:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The bottom of the page now shows Revision: v3.5.3, replacing v3.5.2. This indicates an updated page build/version.
    Difference
    0.1%
    Check dated 2026-04-30T17:25:40.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.2 and removes v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:36:54.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a new record version v3.5.0 to the history; the previous v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:06:18.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision v3.4.3 added to the history; revision v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:57:55.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history and an outdated funding notice was removed; these are minor site maintenance updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T02:24:46.000Z thumbnail image

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.